Randomized study of once-weekly interferon β-la therapy in relapsing multiple sclerosis: Three-year data from the OWIMS study

Mark S. Freedman, G. S. Francis, E. A.C.M. Sanders, G. P.A. Rice, P. O'Connor, G. Comi, P. Duquette, L. Metz, T. J. Murray, J. P. Bouchard, O. Abramsky, J. Pelletier, F. O'Brien, J. de Rijk van Andel, J. P. Story, M. de Milliano, G. Ebers, J. Lesaux, K. Kennedy, P. HoustonJ. Hall, V. Martinelli, G. Santuccio, A. Poggi, M. Gironi, L. Moiola, G. Pepin, J. Poirer, G. Bernier, R. Dubois, R. Bell, D. McGowan, A. Demchuk, E. Harris, M. Yeung, A. Murphy, V. Bhan, C. Maxner, P. Weldon, L. Armstrong, F. Gosselin, M. Thibaut, L. Korouac, A. Morin, D. Karussis, A. Karni, M. Mor, R. Nelson, S. Christie, H. Rabonivitch, C. Freedman, M. Benavente, P. Bensa, A. Dalesky, D. Paty, D. Li, B. Rhodes, A. Riddehough, G. Zhao, X. Wang, Y. Chang, N. Ammoury, A. Galazka, R. Hyde, S. Shah, G. Francis, S. Shahid

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized study of once-weekly interferon β-la therapy in relapsing multiple sclerosis: Three-year data from the OWIMS study'. Together they form a unique fingerprint.

Medicine & Life Sciences